Announcements Trials
Browse Landscape

Phase

Phase 4 5Phase NA 4Phase 3 4Phase 1/2 2Phase 2 1

Status

Completed 4

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Conditions

Polycystic Ovary Syndrome 4Anovulation 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Chorionic Gonadotropin × Clear all
NCT06725004 2025-08-29

Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase 3 Completed
60 enrolled

Polycystic Ovary Syndrome

NCT00747617 2018-11-21

Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)

University of California, San Diego

Phase 3 Completed
25 enrolled 7 charts

Polycystic Ovary Syndrome

NCT01653743 2016-01-07

Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
81 enrolled 11 charts

Anovulation, Polycystic Ovary Syndrome

NCT01185704 2014-02-13

ATTAC-PCO

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
136 enrolled 21 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡